SLAS 2020 International Conference and Exhibition
to Jan 29

SLAS 2020 International Conference and Exhibition

  • 1301 West 22nd Street, Suite 708, Oak Brook IL 60523 USA (map)
  • Google Calendar ICS

Level up your Science

SLAS2020 Educational Program

The Latest in Scientific Discovery, Technology and Innovation: Podium Presentations Offer SLAS2020 Participants Quality Educational Opportunities

Expand your field of view through a world-class scientific program that showcases the top laboratory science and technology podium presentations from industry leaders around the globe. Each podium presentation is hand selected by the SLAS2020 Scientific Program Committee from hundreds of abstract submissions, which are vigorously reviewed. Presentations offer SLAS2020 participants compelling content and fresh perspectives on emerging laboratory technologies from a broad range of industries, including drug discovery and development, informatics, clinical diagnostics, food and agricultural sciences, forensics and security sciences, petrochemicals and energy, and consumer products.

SLAS2020 Educational Tracks

The SLAS2020 scientific program features ten educational tracks, listed below:

  • Advances in Bioanalytics and Biomarkers

  • Assay Development and Screening

  • Automation and High-Throughput Technologies

  • Biologics Discovery

  • Cellular Technologies

  • Data Analysis and Informatics

  • Drug Target Strategies

  • Micro- and Nanotechnologies

  • Molecular Libraries

  • Precision Medicine Technologies

Complete details regarding planned podium sessions for each track will be available in July.

Complete presentation details and the latest schedule of events will be available in the SLAS2020 Event Scheduler, which will launch in late 2019.


View Event →
EMBL conference: Expanding the Druggable Proteome with Chemical Biology
to Feb 7

EMBL conference: Expanding the Druggable Proteome with Chemical Biology

Conference Overview

Despite the exciting advances in human genetics over the past decade, the fraction of the human proteome targeted by small molecules remains relatively small compared to the total number of genes linked to a disease phenotype by Mendelian inheritance or genome-wide association studies. Chemical biology is a scientific discipline that promises to apply the latest chemical approaches to interrogate complex biological systems and is, consequently, at the very heart of modern pharmacology. This conference will explore how recent advances in chemical biology are helping to expand the druggable proteome and enhance our understanding of disease biology with three major themes: 

  • illuminating the druggable genome

  • chemical interrogation of the druggable proteome

  • new engineering approaches for breaking the druggability barrier

Co-organised with industry partners of the EMBL Corporate Partnership Programme, emphasis has been put on bringing together academic and industrial scientists with interests in chemical biology, chemogenomic libraries, pharmacology, medicinal chemistry and bioinformatics who have the curiosity and courage to challenge existing thinking and explore new ways of expanding the druggable proteome for better medicines.



View Event →

SLAS Europe 2019 Conference and Exhibition
to Jun 28

SLAS Europe 2019 Conference and Exhibition

  • Centre de Convencions Internacional de Barcelona (CCIB) (map)
  • Google Calendar ICS

SLAS Europe 2019 offers participants an outstanding scientific programme that features first-class laboratory science and technology podium presentations from global industry leaders. Each podium presentation is hand selected by the SLAS Europe 2019 Scientific Programme Committee from hundreds of abstract submissions, which are rigorously reviewed. Presentations offer SLAS Europe 2019 participants compelling content and innovative perspectives on emerging laboratory technologies and drug discovery and development.

Educational Tracks

The SLAS Europe 2019 Scientific Programme features three educational tracks:

Track 1:  Advances in In Silico Drug Discovery

  • Session – Structure and Simulation

  • Session – Data Science, Analytics, and Informatics

  • Session – Computational Approaches for Interpreting Phenotypic Data

Track 2: Advances in Experimental Drug Discovery

  • Session – Screening in Disease Relevant Models

  • Session – New Approaches in Target Discovery

  • Session – Advances in Biophysical and Bioanalytical Technologies

Track 3: Advances in Laboratory Automation Technology

  • Session – The Rise of Mass Spectroscopy in Early Drug Discovery

  • Session – Next Generation High-Content Bioimaging – Phenotypic Discovery

  • Session – Automation and High-Throughput Technologies

Track 4: Careers, Business and Technology: Explore the Opportunities

  • Session – A Day in the Life Of…

  • Session – Disruptive Ideas and Technologies

  • Session – How to Pitch Ideas to a Big Company

View Event →
ELRIG meeting- Advances in Cell Based Screening in Drug Discovery
to May 24

ELRIG meeting- Advances in Cell Based Screening in Drug Discovery

The third ELRIG meeting on Advances in Cell Based Profiling in Drug Discovery will be held on the 22nd and 23rd of May 2019 at the AstraZeneca R&D premises in Gothenburg. This interactive 2-day event will host leading scientists from academia and industry to discuss current and future formats for cell based assays. This time the bi-annual meeting will be accompanied by a satellite meeting on Chemical Biology on May 24th, organized by key academic infrastructures in the Nordic countries. Our aim is to create an open and inspiring environment for networking between biologists and chemists, working towards a common view on expectations from our cell assays and their use for target identification, target validation and compound profiling purposes.

Plenary Keynote Speakers

Herbert Waldmann (Max Planck Institute of Molecular Physiology, Dortmund)
Olli Kallioniemi (SciLifeLab, KI, Stockholm)
Ulli Elling (Institute of Molecular Biotechnology, IMBA, Vienna)
Craig Crews (Yale University)

Cell based assays are utilized at all stages of drug discovery to explore disease mechanisms and to identify novel molecular therapeutics. Significant advancements are being made towards cell reagents and formats that provide a more accurate biological context, aiming at improving translation to human physiology/pathophysiology. Their implementation is much needed for improving success rates in drug discovery, but there are significant challenges associated with reliable and affordable reagent supply and validation of improved translational power to justify costs. This meeting serves to explore recent advancements and to discuss their practical implementation in drug and chemical probe discovery and validation.

The meeting program is developed around four key focus areas:

Precision Medicine in miniaturized formats

Phenotypic screening through advances in Precise Genome Editing

Multiplexed Screening with Single Cell Resolution

Target Engagement and Coherence with Functional Cellular Responses

ELRIG Chemical Biology Satellite Meeting- 24th May 2018

View Event →